Cerecor, Inc.

Cerecor Inc. is a Maryland-based biopharmaceutical company comprised of a team of industry experts and leading scientists focused on developing neuroscience drugs that make a difference. They are committed to improving the lives of patients and prioritize underserved segments of common diseases. Cerecor exclusively develops products for which human proof-of-concept has been demonstrated and possess biomarkers to guide development. The company’s clinical strategies employ the latest technologies to improve the signal-to-noise ratio and likelihood of trial success.  Current product opportunities are being developed as first-in-class, best-in-class drug candidates in depression and cognitive disorders, including schizophrenia.

Scroll to Top